CoronaVac from Sinovac triggers quick immune response
The Sinovac findings came from results in Phase I and Phase II clinical trials in China involving over 700 participants
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Chinese Vaccine
CanSino gets COVID-19 vaccine patent from China’s IP regulator
As per reports by state media the patent was issued on August 11